MCAS Symptoms, Triggers, Diagnosis and Treatment

MCAS involves sudden, repeated bouts of mast cell chemical release ^1,2. These severe bouts affect several body systems at once ^1,2.

Many episodes look like anaphylaxis, a severe reaction that can threaten life ^1,2. However, symptoms alone cannot confirm MCAS ⁶.

Diagnosis also needs a rise in a mast cell marker during an event ^1,2. Symptoms must also improve with drugs that target mast cells or their chemicals ^1,2.

Mast cells are normal immune cells that help fight infection and aid healing ⁶. They are found across the body, including near blood vessels and in bone marrow ⁸.

Allergens can make mast cells release chemical messengers called mediators ^6,8. Histamine is one well-known mast cell mediator ⁸.

MCAS involves severe and repeated body-wide reactions to these chemicals ^1,2. It does not mean that every ongoing or unexplained symptom comes from mast cells ⁶.

Mast cell activity may occur in allergic inflammation ³. Hives in the skin are one example of a local reaction ³.

Asthma may involve local mast cell activity in the lungs ³. Neither condition alone meets the full MCAS criteria ³.

MCAS affects at least two body systems during the same sudden event ^1,2. Symptoms often ease or go away between these events ⁶.

Mastocytosis is a separate blood disorder with too many mast cells ^6,8. These cells may also be very easy to activate ⁸.

Mastocytosis can cause primary MCAS through abnormal clonal mast cells ^1,3. Clonal cells are abnormal cells that came from one original cell.

A person can have mastocytosis without every symptom being an MCAS event. The full MCAS criteria still guide the diagnosis ^3,4.

Doctors group MCAS by its cause and related health issues. The main groups include:

Several factors may occur in the same person ^3,4. Finding the right group helps guide a more personal care plan ^3,4.

MCAS symptoms begin quickly and involve two or more body systems ^1,5. No single symptom proves that an event is due to MCAS ^3,6.

The pattern matters more than one isolated concern. The same symptoms can occur in many other health problems ^3,6.

Skin symptoms often appear during sudden mast cell reactions ^1,5. Possible skin changes include:

Digestive symptoms may begin with skin or breathing symptoms ^1,5. They can include:

Digestive problems alone do not meet the MCAS criteria ^3,6. Ongoing bloating, constipation, or stomach discomfort also points to other possible causes ⁶.

Breathing effects can include wheezing and chest tightness ¹. Throat tightness may also occur during a body-wide reaction ¹.

Asthma can also cause wheezing without being MCAS ³. Our adult asthma guide explains its symptoms and care.

Mast cell chemicals can affect the heart and blood flow ⁸. An event may cause low blood pressure or a fast heart rate ^1,6.

Headache and “brain fog” have been reported during MCAS events ¹. Brain fog means trouble with focus, memory, or clear thought.

These symptoms matter most when they join other mast cell effects ^1,3. Ongoing brain fog or fatigue alone does not meet the usual criteria ^3,6.

Anaphylaxis is a severe body-wide reaction that can threaten life ^2,8. Many MCAS events take the form of anaphylaxis ^1,2.

Call emergency services now in any of these situations:

MCAS events can follow a known trigger or have no clear cause. A full review should look for allergies and other reasons for mast cell activity ^3,5.

Food or environmental allergies can activate mast cells through IgE ^3,8. IgE is an immune antibody involved in many allergic reactions.

Pollen and certain foods can act as allergens ^6,8. An allergen is a substance that starts an allergic response.

Insect venom can also activate mast cells in someone with that allergy ⁸. Hymenoptera venom comes from insects such as bees and wasps.

Lifelong immunotherapy is recommended for people with Hymenoptera venom sensitivity ². Venom allergy may need long-term allergy treatment ².

Medicines can act as triggers in people who are sensitive to them ⁸. Some drug-triggered reactions can be mast cell activation episodes ^3,5.

NSAIDs can cause drug sensitivity reactions in some people. NSAIDs are pain drugs such as common anti-inflammatory medicines.

Doctors should check for NSAID reactions before calling an event idiopathic ⁵. They should also assess food allergy and other known causes ⁵.

Do not stop a prescribed drug based only on a suspected link. Discuss the timing and reaction with the prescribing clinician.

Mastocytosis is a known risk factor for MCAS ². An allergic tendency and past unexplained anaphylaxis are also risk factors ².

Hereditary alpha-tryptasemia may occur with mast cell symptoms ^1,4. It is an inherited trait linked to mast cell conditions ^1,4.

Clonal cells, allergies, and this inherited trait can overlap ^3,4. Such overlap may raise the need for detailed testing ^3,4.

A risk factor does not confirm MCAS. The three main diagnostic criteria must still be met ⁵.

Trigger review is part of long-term MCAS care ². A written record can help you prepare for an appointment.

Include these details in your record:

Bring this record to an allergy or immune specialist. Avoid blaming every food or exposure without a full review.

MCAS diagnostic criteria require more than symptoms or one high test result ^1,6. The diagnosis uses the event pattern, test results, and treatment response ^1,2.

All three parts must be present for a confirmed diagnosis ^2,7. The required parts are:

Response to medications alone does not prove MCAS ⁶. Many medications can also help symptoms from other causes ⁶.

Symptoms should be severe and occur as clear events ⁵. Ongoing, vague symptoms without such events do not meet the usual criteria ^3,6.

Tryptase is the preferred marker for body-wide mast cell activity ^1,5. It is an enzyme stored and released by mast cells.

Doctors compare an acute result with the person’s usual baseline ^5,6. A single high baseline result does not diagnose MCAS ⁵.

The acute tryptase must exceed baseline by 20% plus 2 ng/mL ^1,5. This rule accounts for each person’s usual level.

For example, clinicians first add 20% to the baseline result. They then add 2 ng/mL to find the needed acute level.

The acute sample should be drawn within four hours of the event ⁵. Tryptase may peak within 30 to 60 minutes after symptoms start ¹.

The baseline sample should follow full recovery by at least 24 hours ¹. Comparing these two results helps show an event-linked rise ^1,5.

Normal results do not always rule out MCAS ⁵. Sample timing and comparison with baseline affect how results are read ^1,5.

Urine tests may help when tryptase testing is unclear or not available ⁵. These tests can measure:

These urine markers are less specific than an event-linked tryptase rise ⁵. Broad symptom-based MCAS criteria lack specificity and supporting evidence ⁵.

A specialist may compare a post-event urine sample with a baseline sample ⁵. The event sample may be taken three to six hours afterward ⁵.

A high baseline urine result alone does not diagnose MCAS ⁵. The change linked to an event provides more useful evidence ⁵.

After confirming mast cell activity, doctors look for its cause ^2,5. This process may include allergy tests for food, venom, or other triggers ^2,5.

Doctors may also measure the baseline tryptase level ^2,5. In people with idiopathic anaphylaxis, a baseline level can be considered alongside other tests for a clonal mast cell disorder ⁵.

A blood test may look for the KIT D816V gene change ^2,5. High-sensitivity testing is preferred when available ⁵.

KIT changes can mark clonal mast cells ^3,8. Finding these cells can support a primary MCAS group ³.

A bone marrow biopsy may follow when clonal disease seems likely ^2,5. This test checks marrow tissue for abnormal mast cells ⁸.

Several health problems can look like MCAS ^3,5. Doctors may consider:

A medical evaluation can help identify the correct diagnosis when symptoms resemble MCAS ⁶. A wrong label may delay care for the actual cause ⁶.

MCAS treatment options depend on event severity and the related subtype ^2,3. A clinician should guide both urgent care and long-term drug use.

People with repeated severe events may receive an epinephrine auto-injector ⁵. A clinician should teach when and how to use it.

Long-term drug care often starts with antihistamines ². These medicines block the effects of histamine.

H1 antihistamines may help itching and other allergy-like symptoms ^1,8. H2 antihistamines target a different histamine receptor ^2,8.

Doctors may use H1 and H2 drugs together ². Other drugs may help symptoms by targeting mast cell mediators or suppressing mast cell activation ².

Possible add-on medicines include these options:

Drug response also forms one part of the diagnosis ^1,2. However, improvement from one drug does not prove MCAS ⁶.

Refractory primary MCAS may need drugs aimed at abnormal mast cells ². Refractory means that standard treatment has not given enough control.

Some people with clonal disease may need cytoreductive treatment ². This treatment lowers the number of abnormal cells.

People with Hymenoptera venom allergy may need lifelong venom immunotherapy ². This therapy gives controlled allergen exposure under specialist care.

Food allergies and NSAID reactions should also be assessed as possible episode triggers ^3,5. Identifying an underlying allergy or other trigger is important in secondary MCAS ^1,3.

A long-term plan may combine trigger avoidance with stepwise medicine use ². Avoidance should focus on triggers found through careful review.

Arrange a medical review for repeated, sudden events affecting several body systems ^1,5. A clinical assessment can review the symptom pattern and include tests for mast cell activation ^2,5.

Ask how to obtain tryptase testing during the next event. Also ask when to collect the baseline sample.

MCAS involves sudden, repeated events in several body systems ^1,2. Isolated or ongoing symptoms do not establish the diagnosis ^3,6.

Confirmation needs an event-linked marker rise and a response to targeted drugs ^1,2. Correctly timed tryptase testing offers the most specific lab support ^1,5.

Specialist care can identify allergies, clonal disease, and other possible causes ^2,5. A personal treatment plan can then address urgent events and long-term control.